東北大学加齢医学研究所 臨床腫瘍学分野 東北大学 腫瘍内科

研究関係

HOME < 研究業績 < 英文論文 2014年度

英文論文 2014年度

  1. Soeda, H.,Shimodaira, H.,Watanabe, M.,Suzuki, T.,Gamo, M.,Takahashi, M.,Komine, K.,Kato, S.,Ishioka, C. KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment. Mol Clin Oncol 2: 356-362 (2014)
  2. Soeda, H.,Shimodaira, H.,Gamoh, M.,Ando, H.,Isobe, H.,Suto, T.,Takahashi, S.,Kakudo, Y.,Amagai, K.,Mori, T.,Watanabe, M.,Yamaguchi, T.,Kato, S.,Ishioka, C. Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801). Oncology 87: 7-20 (2014)
  3. Shiono, M.,Takahashi, S.,Kakudo, Y.,Takahashi, M.,Shimodaira, H.,Kato, S.,Ishioka, C. Upper arm central venous port implantation: a 6-year single institutional retrospective analysis and pictorial essay of procedures for insertion. PLoS One 9: e91335 (2014)
  4. Imai, H.,Kato, S.,Sakamoto, Y.,Kakudo, Y.,Shimodaira, H.,Ishioka, C. High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H. Oncol Rep 31: 1043-50 (2014)
  5. Shiono, M.,Kobayashi, T.,Takahashi, R.,Ueda, M.,Ishioka, C.,Hino, O. Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality. Sci Rep 4: 5927 (2014)
  6. Oda, A.,Saijo, K.,Ishioka, C.,Narita, K.,Katoh, T.,Watanabe, Y.,Fukuyoshi, S.,Takahashi, O. Predicting the structures of complexes between phosphoinositide 3-kinase (PI3K) and romidepsin-related compounds for the drug design of PI3K/histone deacetylase dual inhibitors using computational docking and the ligand-based drug design approach. J Mol Graph Model 54: 46-53 (2014)
  7. Komine, K.,Inoue, M.,Otsuka, K.,Fukuda, K.,Nanjo, H.,Shibata, H. Utility of measuring circulating tumor cell counts to assess the efficacy of treatment for carcinomas of unknown primary origin. Anticancer Res 34: 3165-8 (2014)

ページの先頭へ戻る

© 2006 Department of Medical Oncology, Tohoku University Hospital All rights reserved.